8UX6 | pdb_00008ux6

Structure of Fab201 with a T. parva sporozoite neutralizing B cell epitope of p67


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free: 
    0.251 (Depositor), 0.251 (DCC) 
  • R-Value Work: 
    0.204 (Depositor), 0.204 (DCC) 
  • R-Value Observed: 
    0.206 (Depositor) 

Starting Models: experimental, in silico
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 8UX6

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Molecular characterization of a synthetic neutralizing antibody targeting p67 of Theileria parva.

Miersch, S.Singer, A.U.Chen, C.Fellouse, F.Gopalsamy, A.Costa, L.S.E.Lacasta, A.Chege, H.Chege, N.Nene, V.Sidhu, S.S.

(2025) Protein Sci 34: e70153-e70153

  • DOI: https://doi.org/10.1002/pro.70153
  • Primary Citation Related Structures: 
    8UX6

  • PubMed Abstract: 

    The Theileria parva sporozoite surface antigen p67 is a target of the bovine humoral immune response that generates antibodies capable of providing protection against subsequent infection. As a result, p67 has been the subject of efforts aimed at the development of an anti-sporozoite subunit vaccine. Previous studies have identified neutralizing epitopes in the N- and C-terminal regions of the full-length protein and shown that immunization with a C-terminal fragment of p67 (p67C) alone is capable of eliciting protection. To identify additional neutralizing epitopes in p67C, selections were conducted against it using a phage-displayed synthetic antibody library. An antibody that neutralized the sporozoite in vitro was identified, and the crystal structure of a Fab:peptide complex was elucidated. Mutagenesis studies aimed at validating and further characterizing the Fab:peptide interaction identified critical residues involved in binding and neutralization. This study also validates distinct epitopes for previously reported neutralizing antibodies.


  • Organizational Affiliation
    • The School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada.

Macromolecule Content 

  • Total Structure Weight: 103.84 kDa 
  • Atom Count: 7,202 
  • Modeled Residue Count: 884 
  • Deposited Residue Count: 956 
  • Unique protein chains: 3

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Fab201 light chainA [auth C],
B [auth A]
216Homo sapiensMutation(s): 0 
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
Fab201 heavy chainC [auth B],
D
221Homo sapiensMutation(s): 0 
Find similar proteins by:|  3D Structure
Entity ID: 3
MoleculeChains  Sequence LengthOrganismDetailsImage
p67 protein
E, F
41Theileria parva strain MugugaMutation(s): 0 
UniProt
Find proteins for Q27040 (Theileria parva)
Explore Q27040 
Go to UniProtKB:  Q27040
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ27040
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 6 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
EPE
(Subject of Investigation/LOI)

Query on EPE



Download:Ideal Coordinates CCD File
H [auth C],
R [auth A]
4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID
C8 H18 N2 O4 S
JKMHFZQWWAIEOD-UHFFFAOYSA-N
PEG
(Subject of Investigation/LOI)

Query on PEG



Download:Ideal Coordinates CCD File
AA [auth B]
CA [auth D]
DA [auth D]
EA [auth D]
FA [auth D]
AA [auth B],
CA [auth D],
DA [auth D],
EA [auth D],
FA [auth D],
I [auth C],
Q [auth A]
DI(HYDROXYETHYL)ETHER
C4 H10 O3
MTHSVFCYNBDYFN-UHFFFAOYSA-N
EDO
(Subject of Investigation/LOI)

Query on EDO



Download:Ideal Coordinates CCD File
G [auth C]
JA [auth D]
KA [auth D]
M [auth C]
N [auth C]
G [auth C],
JA [auth D],
KA [auth D],
M [auth C],
N [auth C],
O [auth C],
P [auth C],
S [auth A],
V [auth A],
W [auth A],
X [auth B],
Z [auth B]
1,2-ETHANEDIOL
C2 H6 O2
LYCAIKOWRPUZTN-UHFFFAOYSA-N
CA
(Subject of Investigation/LOI)

Query on CA



Download:Ideal Coordinates CCD File
K [auth C],
L [auth C],
U [auth A]
CALCIUM ION
Ca
BHPQYMZQTOCNFJ-UHFFFAOYSA-N
CL
(Subject of Investigation/LOI)

Query on CL



Download:Ideal Coordinates CCD File
BA [auth B]CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M
NA
(Subject of Investigation/LOI)

Query on NA



Download:Ideal Coordinates CCD File
GA [auth D]
HA [auth D]
IA [auth D]
J [auth C]
T [auth A]
GA [auth D],
HA [auth D],
IA [auth D],
J [auth C],
T [auth A],
Y [auth B]
SODIUM ION
Na
FKNQFGJONOIPTF-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.00 Å
  • R-Value Free:  0.251 (Depositor), 0.251 (DCC) 
  • R-Value Work:  0.204 (Depositor), 0.204 (DCC) 
  • R-Value Observed: 0.206 (Depositor) 
Space Group: P 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 39.01α = 69.26
b = 75.56β = 77.6
c = 90.591γ = 76.08
Software Package:
Software NamePurpose
PHENIXrefinement
MOSFLMdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Bill & Melinda Gates FoundationUnited StatesOPP1078791
Other governmentCanadaCanada Foundation for Innovation Physical Infrastructure Grant #33363
Other governmentCanadaInternational Development Research Centre Joint Canada-Israel Health Research Program #108404-001

Revision History  (Full details and data files)

  • Version 1.0: 2024-10-16
    Type: Initial release
  • Version 1.1: 2025-05-07
    Changes: Database references
  • Version 1.2: 2025-05-28
    Changes: Database references